Medicare’s PAMA-Based CLFS Payment Impact: Strategies to Protect Your Lab’s Revenue


It's clear that Medicare's new pricing system impacted the bottom line of many clinical laboratories, including large and small independent labs, hospital outreach, and physician office laboratories. Please join Lâle White as she sheds light on today's most relevant and valuable topics, such as:

  • Which labs stand to gain and lose the most under Medicare's revised CLFS 
  • Contractual process reviews and reimbursement due diligence that are critical to manage the financial health of labs 
  • What you need to know for the next PAMA data collection period

Contributing Lab Leader

Lale White

Executive Chairman and CEO

Xifin Software

Other LabLeaders Financial resources  / 

Other LabLeaders videos and webinars  /